Boyd Thomas A 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Jun 24, 2010
Insider Transaction Report
Form 4
Boyd Thomas A
Sr. VP, Product Dev.
Transactions
- Sale
Common Stock
2010-06-22$5.74/sh−2,409$13,818→ 36,625 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $5.62 to $5.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.